| 
						Health insurer Anthem's 
						profit, revenue beat estimates 
		 Send a link to a friend 
		
		 [February 01, 2017] 
		(Reuters) - 
		
		Anthem 
		Inc, which is waiting for a ruling on the U.S. government's lawsuit to 
		block its deal to buy Cigna Corp, reported better-than-expected 
		quarterly profit and revenue on Wednesday, helped by strength in its 
		government business. 
 The no. 2 U.S. health insurer's result comes at a time when the 
		insurance industry is likely to change over the next few years as 
		President Donald Trump and the Republican-led Congress move to repeal 
		and replace former President Barack Obama's health reform law, often 
		called Obamacare.
 
 Big insurers, including UnitedHealth Group Inc  and Aetna Inc, 
		largely pulled out of these plans for 2017, saying they were losing too 
		much money.
 
 Anthem, which sells plans to employers as well as government-sponsored 
		health insurance, said it expects 2017 operating revenue of $86.5 
		billion-$87.5 billion and adjusted net income to be greater than $11.50 
		per share.
 
 Analysts on average estimated full-year earnings of $11.53 per share and 
		revenue of $86.68 billion, according to Thomson Reuters I/B/E/S.
 
		
		 
		A U.S. judge blocked health insurer Aetna Inc's proposed $34 billion 
		acquisition of smaller rival Humana Inc last week, raising the stakes 
		for Anthem's $54 billion deal to buy Cigna. The decision for the 
		Anthem-Cigna deal is still pending.
 "We do not see a likelihood of a second round of public mergers ... 
		insurers will move to deploy pent up capital via repurchases and small 
		non-public acquisitions," Piper Jaffray analyst Sarah James said in a 
		client note.
 
 Anthem, which operates Blue Cross Blue Shield health insurance plans in 
		14 states, said earlier this month it extended the deadline for the 
		Cigna deal by three months.
 
			
            [to top of second column] | 
            
			 
            
			The office building of health insurer Anthem is seen in Los Angeles, 
			California February 5, 2015. REUTERS/Gus Ruelas 
            
			 
Cigna 
said on Wednesday it was still evaluating its options and has made no 
determination with respect to Anthem's notice seeking to extend the termination 
date. (http://bit.ly/2jCzUkl)
 Anthem's net income rose to $368.4 million, or $1.37 per share, in the fourth 
quarter ended Dec. 31, from $180.9 million, or 68 cents per share, a year 
earlier.
 
 Excluding items, the company earned $1.76 per share, handily beating analysts' 
average estimate of $1.61.
 
 Total operating revenue rose 7.3 percent to $21.48 billion, above analysts' 
average estimate of $20.92 billion.
 
 Anthem said benefit expense ratio - the percent of premiums spent on claims - 
rose to 87.2 percent in the quarter from 87.0 percent in the year-ago period, 
largely driven by higher medical cost in the Medicaid business, notably in Iowa, 
as well as in the individual business.
 
 (Reporting by Ankur Banerjee in Bengaluru; Editing by Martina D'Couto)
 
				 
			[© 2017 Thomson Reuters. All rights 
				reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			 
			 |